A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
Biomedicine & pharmacotherapy, 2021-01, Vol.133, p.111037-111037, Article 111037 [Peer Reviewed Journal]2021 The Authors ;Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved. ;2021 The Authors 2021 ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2020.111037 ;PMID: 33249281
Full text available